Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EBT: 2011-2024

Historic EBT for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $25.7 million.

  • Veracyte's EBT rose 12.11% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.0 million, marking a year-over-year increase of 479.51%. This contributed to the annual value of $25.7 million for FY2024, which is 133.60% up from last year.
  • Latest data reveals that Veracyte reported EBT of $25.7 million as of FY2024, which was up 133.60% from -$76.6 million recorded in FY2023.
  • In the past 5 years, Veracyte's EBT ranged from a high of $25.7 million in FY2024 and a low of -$81.6 million during FY2021.
  • Its 3-year average for EBT is -$29.1 million, with a median of -$36.4 million in 2022.
  • As far as peak fluctuations go, Veracyte's EBT plummeted by 177.06% in 2020, and later skyrocketed by 133.60% in 2024.
  • Yearly analysis of 5 years shows Veracyte's EBT stood at -$34.9 million in 2020, then slumped by 133.89% to -$81.6 million in 2021, then soared by 55.39% to -$36.4 million in 2022, then crashed by 110.32% to -$76.6 million in 2023, then soared by 133.60% to $25.7 million in 2024.